FDA Inspection 1225587 — Xenex Laboratories Inc.

Xenex Laboratories Inc. — FEI 3007170694

The FDA completed an inspection of Xenex Laboratories Inc. on Nov 15, 2023 in Coquitlam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 15, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Coquitlam (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.